Giving what was once considered little more than a psychedelic “party drug” to people suffering from post-traumatic stress disorder can dramatically increase the effectiveness of therapy, a new study suggests. Researchers from the University of California made the claim Tuesday at a virtual symposium after conducting a phase III medical trial involving 90 participants. For...
